Literature DB >> 21645555

Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation.

Alkomiet Hasan1, Michael A Nitsche, Bettina Rein, Thomas Schneider-Axmann, Birgit Guse, Oliver Gruber, Peter Falkai, Thomas Wobrock.   

Abstract

Neural and cortical plasticity represent the ability of the brain to reorganize its function in response to a challenge. Plasticity involves changing synaptic activity and connectivity. Long-term-potentiation is one important mechanism underlying these synaptic changes. Disturbed neuronal plasticity is considered to be part of the pathophysiology of schizophrenia and has been linked to the different clinical features of this severe illness. The aim of the present study was to investigate nonfocal cortical plasticity and cortical excitability in recent-onset and multi-episode schizophrenia compared with healthy subjects. Nonfocal cortical plasticity can be induced in the motor cortex of healthy subjects with anodal transcranial direct current stimulation. Animal and human research indicates that this long-term-potentiation-like plasticity is glutamate-dependent and that these plasticity shifts can last for several hours. Transcranial direct current stimulation-induced plasticity was monitored by transcranial magnetic stimulation-generated motor evoked potentials. Well-characterized transcranial magnetic stimulation protocols were applied to determine the physiological basis of plasticity changes. Multi-episode schizophrenia patients showed significantly reduced long-term-potentiation-like plasticity compared to recent-onset schizophrenia patients and healthy controls. All schizophrenia patients demonstrated reduced cortical inhibition. Our results indicate that the long-term-potentiation-like plasticity deficit in schizophrenia patients is related to the disease course. Disturbances of N-methyl-d-aspartate, gamma-aminobutyric acid and dopamine receptors may account for this plasticity deficit. LTP-like plasticity deficits might be related to disturbed information processing in schizophrenia patients.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645555     DOI: 10.1016/j.bbr.2011.05.017

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  56 in total

1.  Motor cortical plasticity in schizophrenia: A meta-analysis of Transcranial Magnetic Stimulation - Electromyography studies.

Authors:  Urvakhsh Meherwan Mehta; Milind Vijay Thanki; Jaya Padmanabhan; Alvaro Pascual-Leone; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2018-11-06       Impact factor: 4.939

Review 2.  GABA abnormalities in schizophrenia: a methodological review of in vivo studies.

Authors:  Stephan F Taylor; Ivy F Tso
Journal:  Schizophr Res       Date:  2014-10-25       Impact factor: 4.939

Review 3.  Targeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.

Authors:  Kim Q Do; Michel Cuenod; Takao K Hensch
Journal:  Schizophr Bull       Date:  2015-06-01       Impact factor: 9.306

4.  Critical period plasticity-related transcriptional aberrations in schizophrenia and bipolar disorder.

Authors:  Milo R Smith; Ben Readhead; Joel T Dudley; Hirofumi Morishita
Journal:  Schizophr Res       Date:  2018-11-12       Impact factor: 4.939

5.  Aberrant Middle Prefrontal-Motor Cortex Connectivity Mediates Motor Inhibitory Biomarker in Schizophrenia.

Authors:  Xiaoming Du; Fow-Sen Choa; Joshua Chiappelli; Krista M Wisner; George Wittenberg; Bhim Adhikari; Heather Bruce; Laura M Rowland; Peter Kochunov; L Elliot Hong
Journal:  Biol Psychiatry       Date:  2018-06-21       Impact factor: 13.382

6.  Loss of α1,6-Fucosyltransferase Decreases Hippocampal Long Term Potentiation: IMPLICATIONS FOR CORE FUCOSYLATION IN THE REGULATION OF AMPA RECEPTOR HETEROMERIZATION AND CELLULAR SIGNALING.

Authors:  Wei Gu; Tomohiko Fukuda; Tomoya Isaji; Qinglei Hang; Ho-hsun Lee; Seiichiro Sakai; Jyoji Morise; Junya Mitoma; Hideyoshi Higashi; Naoyuki Taniguchi; Hiromu Yawo; Shogo Oka; Jianguo Gu
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

Review 7.  Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.

Authors:  Alkomiet Hasan; Amanda Mitchell; Anja Schneider; Tobias Halene; Schahram Akbarian
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-02-05       Impact factor: 5.270

Review 8.  Synaptic plasticity in neurodegenerative diseases evaluated and modulated by in vivo neurophysiological techniques.

Authors:  F Pilato; P Profice; F Ranieri; F Capone; R Di Iorio; L Florio; V Di Lazzaro
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

9.  Test-retest reliability of short-interval intracortical inhibition and intracortical facilitation in patients with schizophrenia.

Authors:  Xiaoming Du; L Elliot Hong
Journal:  Psychiatry Res       Date:  2018-06-19       Impact factor: 3.222

Review 10.  Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studies.

Authors:  Rae Price; Bahar Salavati; Ariel Graff-Guerrero; Daniel M Blumberger; Benoit H Mulsant; Zafiris J Daskalakis; Tarek K Rajji
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-05-10       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.